Lenetix Launches Screening Study of New Down Syndrome Test

Lenetix, Inc. announced the launch of an Institutional Review Board (IRB)-approved screening study of an improved first and second trimester non-invasive fetal diagnostic test to detect Down syndrome.
RedOrbit